Healthcare Regulation (HIPAA)

eHealth is ditching its transactional model for lifelong support, but can it win over skeptical consumers and investors in a competitive market?

The new strategic alliance aims to slash AI deployment times and solve governance challenges, making Palantir's powerful platforms accessible to more businesses.

A new report reveals how AI search, data privacy, and patient trust are forcing medical practices to adopt a radically new playbook to attract patients.

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?

A lawsuit claims a specialized pediatric daycare failed to protect a vulnerable child, leading to unexplained injuries and a state investigation.

Passwork's latest update introduces new restrictions on personal password vaults, aiming to curb shadow IT and bolster enterprise data protection.

The deal, backed by private equity, aims to streamline complex Medicaid billing, impacting both hospital finances and patient access to care.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

Innovia Consulting acquires 365Vertical and 365 Cannabis, a strategic move to dominate specialized ERP markets like cannabis and agriculture.

Zemcelpro® gains key reimbursement status, offering immediate hope and access for German patients with limited options and paving a new path for cell therapy.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

Dr. Batra's launches XODerma, a high-tech exosome skin therapy in Dubai, blending homeopathy with cellular science. But does the hype outpace regulation?

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

Disc Medicine's promising EPP drug hits a major roadblock as the FDA seeks more data, delaying hope for patients and setting up a high-stakes trial.

Canada's elections commissioner has sanctioned former minister Chrystia Freeland and others for breaking election laws, highlighting ongoing integrity challenges.

A new online pharmacy is challenging the 'prescribe and forget' model for weight loss drugs, offering integrated clinical care to combat safety concerns.

The firm reports a $195M cash reserve but a wider net loss as it nears crucial data readouts for its novel depression and anxiety drug candidates.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

Irish firm InVera Medical wins CE Mark for a new varicose vein device, promising a less invasive, office-based treatment for a widespread condition.

Finnish medtech firm Bioretec reports staggering 2025 losses but bets its future on breakthrough implant technology and a complete strategic overhaul.